Thresholds for the cost–effectiveness of interventions: alternative approaches

Cited by (853)

Items 101–200 of 853

1. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation
   Sihui Zhang, Chao Wang, Bei Liu, Qing‐Bin Lu, Jia Shang, Yi‐Hua Zhou, Jidong Jia, Xiaoyuan Xu, Huiying Rao, Bingfeng Han et al. · 2023 · The Lancet Regional Health - Western Pacific
2. Impact and cost-effectiveness of rotavirus vaccination in Bangladesh
   Clint J Pecenka, Umesh D. Parashar, Jacqueline E. Tate, Jahangir A. M. Khan, Devin Groman, Stephen Chacko, Md Shamsuzzaman, Andrew David Clark, Deborah Atherly · 2017 · Vaccine
3. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study
   Man, Irene, Georges, Damien, de Carvalho, Tiago M, Ray Saraswati, Lopamudra, Bhandari, Prince, Kataria, Ishu, Siddiqui, Mariam, Muwonge, Richard, Lucas, Eric, Berkhof, Johannes et al. · 2022 · The Lancet Oncology
4. Improving learning and accountability in foreign aid
   Paul Clements · 2019 · World Development
5. A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain
   Mac Ardy Junio Gloria, Montarat Thavorncharoensap, Usa Chaikledkaew, Sitaporn Youngkong, Ammarin Thakkinstian, Anthony J. Culyer · 2021 · Value in Health
6. Cost-effectiveness of interventions to prevent road traffic injuries in low- and middle-income countries: A literature review
   Amrit Banstola, Julie A. Mytton · 2016 · Traffic Injury Prevention
7. Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program
   Nicole T. A. Rosendaal, Marleen Elisabeth Hendriks, Mark D. Verhagen, Oladimeji Akeem Bolarinwa, Emmanuel Olatunde Sanya, Philip Manma Kolo, Peju Adenusi, Kayode Agbede, Diederik van Eck, Siok Swan Tan et al. · 2016 · PLoS ONE
8. Incremental cost and cost-effectiveness of low-dose, high-frequency training in basic emergency obstetric and newborn care as compared to status quo: part of a cluster-randomized training intervention evaluation in Ghana
   Michelle Willcox, Heather Harrison, Amos Asiedu, Allyson R. Nelson, Patricia P. Gomez, Amnesty Elizabeth LeFevre · 2017 · Globalization and Health
9. A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States
   Nikhil Ravi Thiruvengadam, Monica Saumoy, Yecheskel Schneider, Sara Attalla, Joseph Triggs, Peter Lee, Michael L. Kochman · 2021 · Clinical Gastroenterology and Hepatology
10. Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis
    Hugo C. Turner, Alison A. Bettis, Brian K Chu, Deborah A. McFarland, Pamela J. Hooper, Sunny Doodu Mante, Christopher Fitzpatrick, Mark Bradley · 2016 · Clinical Infectious Diseases
11. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study
    Nicole G. Campos, Vivien Davis Tsu, José Jerónimo, Mercy Mvundura, Jane J. Kim · 2017 · BMC Cancer
12. Cost–effectiveness of emergency care interventions in low and middle-income countries: a systematic review
    Kalin Werner, Nicholas Risko, Taylor W. Burkholder, Kenneth Munge, Lee Alan Wallis, Teri Ann Reynolds · 2020 · Bulletin of the World Health Organization
13. Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers
    John Robert Hurst, Gina Agarwal, Job F. M. van Boven, Meena Daivadanam, Gillian S. Gould, Erick Wan-Chun Huang, Pallab Kumar Maulik, J. Jaime Miranda, Mayowa Ojo Owolabi, Shahirose Premji et al. · 2020 · BMJ Open
14. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa
    Jan A. C. Hontelez, Angela Y. Chang, Osondu Ogbuoji, Sake J. de Vlas, Till Bärnighausen, Rifat Ali Atun · 2016 · AIDS
15. Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
    Kalipso Chalkidou, Ryan Li, Anthony J. Culyer, Amanda L. Glassman, Karen Joanne Hofman, Yot Teerawattananon · 2016 · International Journal of Health Policy and Management
16. The US President's Malaria Initiative, Plasmodium falciparum transmission and mortality: A modelling study
    Peter Winskill, Hannah Slater, Jamie T. Griffin, Azra C. Ghani, Patrick G. T. Walker · 2017 · PLoS Medicine
17. Evidence on result-based financing in maternal and child health in low- and middle-income countries: a systematic review
    Nigel F James, Kenny D. Lawson, Yubraj Acharya · 2020 · Global Health Research and Policy
18. Natural history of human papillomavirus and vaccinations in men: A literature review
    Benjamin J. Lieblong, Brooke E. E. Montgomery, L. Joseph Su, Mayumi Nakagawa · 2019 · Health Science Reports
19. Healthcare at the Beginning of Life and Child Survival: Evidence from a Cash Transfer Experiment in Nigeria
    E. Okeke, I. Abubakar · 2019 · Journal of Development Economics
20. The Safer Nursing Care Tool as a guide to nurse staffing requirements on hospital wards: observational and modelling study
    Peter Griffiths, Christina E. Saville, Jane Ball, Rosemary Chable, Andrew Michael Dimech, Jeremy Jones, Yvonne Jeffrey, Natalie A. Pattison, Alejandra Recio‐Saucedo, Nicola Sinden et al. · 2020 · Health Services and Delivery Research
21. Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs
    Lukyn M. Gedge, Alison A. Bettis, Mark Bradley, T. Déirdre Hollingsworth, Hugo C. Turner · 2018 · Parasites & Vectors
22. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
    Clint J Pecenka, Frédéric Debellut, Naor Bar‐Zeev, Palwasha Anwari, Justice Nonvignon, Md Shamsuzzaman, Andrew David Clark · 2018 · Vaccine
23. Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece
    Theodoros V. Giannouchos, Dimos Dimitrios Mitsikostas, Robert L. Ohsfeldt, Athanassios Vozikis, Paraskevi Koufopoulou · 2019 · Clinical Drug Investigation
24. Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions
    Stavros Simeonidis, Stefania Koutsilieri, Athanassios Vozikis, D.N. Cooper, Christina Mitropoulou, George P. Patrinos · 2019 · Frontiers in Pharmacology
25. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program
    Thirunavukkarasu Sathish, Brian F. Oldenburg, Kavumpurathu Raman Thankappan, Pilvikki Absetz, Jonathan E. Shaw, Robyn Jennifer Tapp, Paul Zimmet, Sajitha Balachandran, Suman Surendra Shetty, Zahra Aziz et al. · 2020 · BMC Medicine
26. Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review
    Neily Zakiyah, Antoinette D. I. van Asselt, Frank Roijmans, Maarten Jacobus Postma · 2016 · PLoS ONE
27. Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis
    Naren Kumar Surendra, Mohd Rizal Abdul Manaf, Lai Seong Hooi, Sunita Bavanandan, Fariz Safhan Mohamad Nor, Shahnaz Shah Firdaus Khan, Ong Loke Meng, Abdul Halim Abdul Gafor · 2019 · PLoS ONE
28. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System
    Ângela Jornada Ben, Jeruza Lavanholi Neyeloff, Camila Franciele de Souza, Ana Paula Oliveira Rosses, Aline Lütz de Araújo, Adriana Szortika, Franciele Locatelli, Gabriela de Carvalho, Cristina Rolim Neumann · 2019 · Applied Health Economics and Health Policy
29. Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience
    For the CNDDM Working Group, Cristiana Maria Toscano, Xiaohui Zhuo, Kumiko Imai, Bruce Bartholow Duncan, Carísi Anne Polanczyk, Ping Zhang, Michael Maurice Engelgau, María Inês Schmidt · 2015 · Diabetology & Metabolic Syndrome
30. Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting
    Paul Jülicher, Claudio Galli · 2017 · Journal of Medical Economics
31. A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection
    Hannah E. Burton, Stephen Mitchell, Maureen Watt · 2017 · PharmacoEconomics
32. Cost‐effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource‐limited setting
    Bin Yan Wu, Xu Wan, Jing Ma · 2017 · Journal of Diabetes
33. Implementation, efficacy, costs and processes of inpatient equivalent home-treatment in German mental health care (AKtiV): protocol of a mixed-method, participatory, quasi-experimental trial
    Johanna Baumgardt, Julian Schwarz, Andreas Bechdolf, Konstantinos Nikolaidis, Martin Heinze, Johannes Hamann, Martin Holzke, Gerhard Längle, Janina Richter, Peter Brieger et al. · 2021 · BMC Psychiatry
34. Promoting innovation while controlling cost: The UK's approach to health technology assessment
    Michael Anderson, Michael Drummond, David G. Taylor, Alistair J McGuire, Paul Carter, Elias A. Mossialos · 2022 · Health Policy
35. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States
    Sun Young Kim, Chi Nguyen, Louise B. Russell, Sara M. Tomczyk, Fatimah Abdul-Hakeem, Stephanie J. Schrag, Jennifer R. Verani, Anushua Sinha · 2017 · Vaccine
36. Multiple Micronutrient Supplements Are More Cost-effective Than Iron and Folic Acid: Modeling Results from 3 High-Burden Asian Countries
    Bahman Kashi, Caroline Godin, Zuzanna Kurzawa, Allison Verney, Jennifer Busch‐Hallen, Luz Maria De‐Regil · 2019 · Journal of Nutrition
37. Cost-effectiveness analysis of malaria rapid diagnostic tests for appropriate treatment of malaria at the community level in Uganda
    Kristian Schultz Hansen, Richard Ndyomugyenyi, Pascal Magnussen, Sham D. Lal, Siân E. Clarke · 2016 · Health Policy and Planning
38. How do decision-makers use evidence in community health policy and financing decisions? A qualitative study and conceptual framework in four African countries
    Meghan Bruce Kumar, Miriam Taegtmeyer, Jason J. Madan, Sozinho Daniel Ndima, Kingsley Rex Chikaphupha, Aschenaki Zerihun Kea, Edwine Barasa · 2020 · Health Policy and Planning
39. Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma
    Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, Lihua Elizabeth Budde, Matthew Genyeh Mei, Leslie L. Popplewell, Tanya Siddiqi, Jasmine M. Zain et al. · 2022 · Blood
40. Cost-Effectiveness of Surveillance for Bloodstream Infections for Sepsis Management in Low-Resource Settings
    Erin Penno, Sarah Baird, John A. Crump · 2015 · American Journal of Tropical Medicine and Hygiene
41. Global economic evaluations of rotavirus vaccines: A systematic review
    Surachai Kotirum, Naaon Vutipongsatorn, Khachen Kongpakwattana, Raymond C. W. Hutubessy, Nathorn Chaiyakunapruk · 2017 · Vaccine
42. Cost effectiveness of endoscopic gallbladder drainage to treat acute cholecystitis in poor surgical candidates
    Juan E. Corral, Ananya Das, Paul Thomas Kröner, Victoria Gómez, Michael B. Wallace · 2019 · Surgical Endoscopy
43. A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme
    Ijeoma Edoka, Ciaran Navin Kohli-Lynch, Heather Fraser, Karen Hofman, Stefano Tempia, Meredith McMorrow, Wayne Ramkrishna, Philipp Lambach, Raymond C. W. Hutubessy, Cheryl Cohen · 2020 · Vaccine
44. Screening for breast cancer
    Gauravi A. Mishra, Sharmila Anil Pimple, Indraneel Mittra, Rajendra Achyut Badwe · 2021 · The Indian Journal of Medical Research
45. Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in China
    Yamin Shu, Yufeng Ding, Qilin Zhang · 2022 · Frontiers in Oncology
46. Are current preventive chemotherapy strategies for controlling and eliminating neglected tropical diseases cost-effective?
    Hugo C. Turner, Wilma A. Stolk, Anthony W. Solomon, Jonathan D. King, Antonio Montresor, David Hurst Molyneux, Jaspreet Toor · 2021 · BMJ Global Health
47. Cost‐Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients
    Drayton A. Hammond, Niranjan J. Kathe, Anuj Shah, Bradley C. Martin · 2016 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
48. Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review
    Scott Dennis Grosse, Cora Peterson, Rahi Abouk, Jill Glidewell, Matthew E. Oster · 2017 · International Journal of Neonatal Screening
49. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan
    Richard Rheingans, John D. Anderson, Karoun H. Bagamian, Lindsey A. Laytner, Clinton J. Pecenka, Syed Saqlain Ahmad Gilani, Munir Ahmed · 2018 · Vaccine
50. Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States
    Patrick W. Sullivan, Qianyi Li, S. Pinar Bilir, Joseph Dang, Abhishek Kavati, Ming Yang, Yamina Rajput · 2019 · Current Medical Research and Opinion
51. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients at lower surgical risk: results from the NOTION trial
    Benjamin P. Geisler, Torben Jørgensen, Hans Gustav Hørsted Thyregod, Jan Benjamin Pietzsch, Lars Søndergaard · 2019 · EuroIntervention
52. Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland
    Arjun Bhadhuri, Ralph P. Insinga, Patrik Guggisberg, Cédric Michael Panje, Matthias M. Schwenkglenks · 2019 · Swiss Medical Weekly
53. Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial
    Sarah Gimbel, Ana Olga Mocumbi, Kristjana Ásbjörnsdóttir, Joana Coutinho, Leonel Andela, Bonifacio Rodriguez Cebola, Heidi Craine, Jonny Crocker, Leecreesha Hicks, Sarah Holte et al. · 2020 · Implementation Science
54. Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review
    K. Śmiłowska, D. V. van Wamelen, T. Pietrzykowski, Alexander Calvano, C. Rodríguez-Blázquez, P. Martínez-Martín, P. Odin, K. Chaudhuri · 2020 · Journal of Parkinson's Disease
55. Resource requirements and reduction in cardiac mortality from deep inspiration breath hold (DIBH) radiation therapy for left sided breast cancer patients: A prospective service development analysis
    Sanjoy Chatterjee, Santam Chakraborty, Moses A. Arunsingh, Chandran Nallathambi, Anurupa Mahata, S. Mandal, Rimpa Basu Achari, Indranil Mallick, Raj Kumar Shrimali, Tapesh Bhattacharyya et al. · 2018 · Practical Radiation Oncology
56. Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
    Mira D. Franken, E.M. van Rooijen, Anne Maria May, Hendrik Koffijberg, Harm van Tinteren, Linda Mol, Albert J. ten Tije, G. J. M. Creemers, Ankie M.T. van der Velden, Bea C. Tanis et al. · 2017 · European Journal of Cancer
57. Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure
    Guido España, Yutong Yao, Kathryn B. Anderson, Meagan C. Fitzpatrick, David L. Smith, Amy C. Morrison, Annelies Wilder‐Smith, Thomas W. Scott, T. Alex Perkins · 2019 · PLoS neglected tropical diseases
58. Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-effectiveness analysis
    Jiaqi Han, Kun Tian, Jianping Yang, Youling Gong · 2020 · Lung Cancer
59. Plant-made immunotoxin building blocks: A roadmap for producing therapeutic antibody-toxin fusions
    Matthias Knödler, Johannes F. Buyel · 2020 · Biotechnology Advances
60. Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece
    Charalampos Tzanetakos, George Gourzoulidis · 2023 · Value in Health Regional Issues
61. Economic evaluations of gestational diabetes mellitus screening: a systematic review
    Mo, Xiuting, Gai Tobe, Ruoyan, Takahashi, Yoshimitsu, Arata, Naoko, Liabsuetrakul, Tippawan, Nakayama, Takeo, Mori, Rintaro · 2021 · Journal of Epidemiology
62. Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis
    Michelle Vogelzang, Fern Terris‐Prestholt, Peter T. Vickerman, Sinéad Delany‐Moretlwe, Danielle Travill, Matthew Quaife · 2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes
63. Impact and economic evaluation of a novel HIV service delivery model in rural Malawi
    Ryan K. McBain, Elizabeth M. Petersen, Nora Tophof, Elizabeth L. Dunbar, Noel Kalanga, Lawrence Nazimera, Andrew Mganga, Luckson Dullie, Joia S. Mukherjee, Emily B Wroe · 2017 · AIDS
64. Outlook for tuberculosis elimination in California: An individual-based stochastic model
    Alex J. Goodell, Priya B. Shete, Rick A. Vreman, Devon McCabe, Travis C. Porco, Pennan M. Barry, Jennifer Flood, Suzanne M. Marks, Andrew N Hill, Adithya Cattamanchi et al. · 2019 · PLoS ONE
65. The Benefits and Costs of a U.S. Child Allowance
    Irwin Garfinkel, Laurel Sariscsany, Elizabeth Ananat, Sophie M. Collyer, Robert Paul Hartley, Buyi Wang, Christopher Wimer · 2022 · SSRN Electronic Journal
66. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability
    Jan Hendriks, Raymond C. W. Hutubessy, Gary S. Grohmann, Guido Torelli, Martin Friede, Marie-Paule Kiény · 2018 · Vaccine
67. Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States
    Robert I. Haddad, Ezra E.W. Cohen, M. Venkatachalam, Kate C. Young, Prianka Singh, James W. Shaw, Beata Korytowsky, Pranav Abraham, Kevin Joseph Harrington · 2020 · Journal of Medical Economics
68. Cost-Effectiveness of a Continuous Glucose Monitoring Mobile App for Patients With Type 2 Diabetes Mellitus: Analysis Simulation
    Shintaro Tsuji, Tomoki Ishikawa, Yasuhiro Morii, Hongjian Zhang, Teppei Suzuki, Takumi Tanikawa, Jun Nakaya, Katsuhiko Ogasawara · 2020 · Journal of Medical Internet Research
69. Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia
    Youngji Jo, Mary Kagujje, Karl Johnson, David W. Dowdy, Peter Hangoma, Lophina Chiliukutu, Monde Muyoyeta, Hojoon Sohn · 2021 · PLoS ONE
70. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting
    Nicole G. Campos, Vivien Davis Tsu, José Jerónimo, Denise Njama‐Meya, Mercy Mvundura, Jane J. Kim · 2017 · Health Policy and Planning
71. Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
    Natalie Carvalho, Mark Jit, Sarah Cox, Joanne Yoong, Raymond C. W. Hutubessy · 2017 · PharmacoEconomics
72. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries
    Cameron M. Wright, Lydia Boudarène, Ninh Thi Ha, Olívia Wu, Neil Hawkins · 2018 · BMC Public Health
73. Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda
    Laura Di Giorgio, Mercy Mvundura, Justine Komunyena Tumusiime, Chloe Morozoff, Jane Cover, Jennifer Kidwell Drake · 2018 · Contraception
74. Willingness to pay for one quality-adjusted life year in Iran
    Najmeh Moradi, Arash Rashidian, Shirin Nosratnejad, Alireza Olyaeemanesh, Marzieh Zanganeh, Leila Zarei · 2019 · Cost Effectiveness and Resource Allocation
75. Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial
    Valesca P. Retèl, Danalyn Byng, Sabine C. Linn, Katarzyna Jóźwiak, Hendrik Koffijberg, Emiel J. Th. Rutgers, Fátima Cardoso, Martine J Piccart, Coralie Poncet, Laura J. van’t Veer et al. · 2020 · European Journal of Cancer
76. Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018
    Mark Jit · 2020 · Value in Health
77. Evaluating the Impact of Cost on the Treatment Algorithm for Chronic Idiopathic Constipation: Cost-Effectiveness Analysis
    Eric D. Shah, Kyle D. Staller, Judy W. Nee, Nitin K. Ahuja, Walter W. Chan, Anthony J Lembo, Darren M. Brenner, Corey Allan Siegel, William D. Chey · 2021 · The American Journal of Gastroenterology
78. Cost-effectiveness analysis of serplulimab plus chemotherapy in the first-line treatment for PD-L1-positive esophageal squamous cell carcinoma in China
    Shixian Liu, Nana Jiang, Lei Dou, Shunping Li · 2023 · Frontiers in Immunology
79. Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low‐ and Middle‐Income Countries: A Systematic Literature Review
    Tom Drake, Angela Devine, Shunmay Yeung, Nicholas P. J. Day, Lisa J. White, Yoel Lubell · 2016 · Health Economics
80. Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults
    Ira Lewis Leeds, Vasanthakumar Namasivayam, Assanatou Bamogo, Prithvi Sankhla, Winter Maxwell Thayer · 2018 · American Journal of Preventive Medicine
81. Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya
    John Ojal, Ulla Kou Griffiths, Laura L. Hammitt, Ifedayo Adetifa, Donald O. Akech, Collins W. Tabu, J. Anthony G. Scott, Stefan Flasche · 2019 · The Lancet Global Health
82. Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare
    Pricivel M. Carrera, Maarten J. IJzerman · 2016 · Expert Review of Pharmacoeconomics & Outcomes Research
83. Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany
    Katharina Kähm, Wolf H. Rogowski, Sigrid Adler-Reichel, Amanda Tufman, Rudolf Maria Huber, Björn Stollenwerk · 2015 · PharmacoEconomics
84. Cost-effectiveness analysis of initial nonoperative management versus emergency laparoscopic appendectomy for acute complicated appendicitis
    Kiyoaki Sugiura, Keiichi Suzuki, Tomoshige Umeyama, Kenshi Omagari, Takeo Hashimoto, Akihiko Tamura · 2020 · BMC Health Services Research
85. Cost-Effectiveness of Improved Hypertension Management in India through Increased Treatment Coverage and Adherence: A Mathematical Modeling Study
    Hemanshu Das, Andrew Edward Moran, Anupam Khungar Pathni, Bhawna Sharma, Abhishek Kunwar, Sarang Deo · 2021 · Global Heart
86. Cost‐Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
    Ahmad Gholami, Jassem Azizpoor, Elham Aflaki, Mehdi Rezaee, Khosro Keshavarz · 2021 · BioMed Research International
87. The Value of a Statistical Life-Year in Sub-Saharan Africa: Evidence From a Large Population-Based Survey in Tanzania
    Bryan Patenaude, Innocent Antony Semali, Japhet Killewo, Till Bärnighausen · 2019 · Value in Health Regional Issues
88. The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease
    Domenico R. Nastasi, Joseph Vaughan Moxon, Richard Norman, Alexandra F. Trollope, Sophie E. Rowbotham, Frank Quigley, Jason S. Jenkins, Jonathan Golledge · 2020 · Journal of Vascular Surgery
89. Interpretation of trial-based economic evaluations of musculoskeletal physical therapy interventions
    Gisela Cristiane Miyamoto, Ângela Jornada Ben, Judith Ekkina Bosmans, Maurits W. van Tulder, Chung‐Wei Christine Lin, Cristina Maria Nunes Cabral, Johanna Maria van Dongen · 2021 · Brazilian Journal of Physical Therapy
90. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective
    Hsuan‐Yu Su, Chenyi Yang, Huang‐Tz Ou, Shyi-Gen Chen, Jui-Ching Chen, Hui‐Ju Ho, Shihchen Kuo · 2023 · JAMA Network Open
91. Sustainable Financing of Innovative Therapies: A Review of Approaches
    Aidan Hollis · 2016 · PharmacoEconomics
92. Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review
    Leor T. Arbel, Edmund Hsu, Keegan S McNally · 2017 · Cureus
93. Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment
    Philippe Van Wilder, Irina Odnoletkova, Mehdi Mouline, Esther de Vries · 2021 · PLoS ONE
94. Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States
    Cheryl A. Neslusan, Anna R. Teschemaker, Michael S. Willis, Pierre Johansen, Lien Vo · 2018 · Diabetes Therapy
95. Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran
    Mohsen Yaghoubi, Marzieh Nojomi, Atefeh Vaezi, Vida Erfani, Susan Mahmoudi, Khadijeh Ezoji, Seyed Mohsen Zahraei, Irtaza Ahmad Chaudhri, Maziar Moradi‐Lakeh · 2018 · Value in Health Regional Issues
96. Snakebite: An Exploratory Cost-Effectiveness Analysis of Adjunct Treatment Strategies
    Benjamin Herzel, Stephen Paul Samuel, Tommaso C. Bulfone, C. Soundara Raj, Matthew R. Lewin, James G. Kahn · 2018 · American Journal of Tropical Medicine and Hygiene
97. Cost-Benefit Limitations of Extended, Outpatient Venous Thromboembolism Prophylaxis Following Surgery for Crohn’s Disease
    Ira Lewis Leeds, Sandra R. DiBrito, Joseph K. Canner, Elliott Richard Haut, Bashar A. Safar · 2019 · Diseases of the Colon & Rectum
98. Economic evaluation of physical activity interventions for type 2 diabetes management: a systematic review
    Barbosa, Ana, Whiting, Stephen, Ding, Ding, Brito, João, Mendes, Romeu · 2022 · European Journal of Public Health
99. Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan
    Chia‐Te Liao, Tung-Han Hsieh, Chia-Yin Shih, Ping‐Yen Liu, Jung‐Der Wang · 2021 · Scientific Reports
100. Impact of clean intermittent catheterization on quality adjusted life years (QALYs) in spinal cord injury patients with neurogenic urinary incontinence
     Ján Švihra, Jan Krhút, Roman Zachoval, Viera Švihrová, J. Ľupták · 2017 · Neurourology and Urodynamics